NRTI resistance associated with the RT mutation K70E in HIV-1

被引：0
|
作者：
Van Houtte, M.
Staes, M.
Geretti, A. M.
Pattery, T.
Bacheler, L.
机构：
[1] Vicro BVBA, Mechelen, Belgium
[2] UCL Royal Free Hosp, London NW3 2QG, England
[3] UCL Royal Free & Univ Coll Med Sch, London, England
[4] Vicro Lab Inc, Durham, NC USA
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [21] Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition in HIV-1 RT of Subtypes B and C
    Cunha, Rodrigo D.
    Abreu, Celina M.
    Gonzalez, Luis M. F.
    Nijhuis, Monique
    de Jong, Dorien
    Aguiar, Renato S.
    Afonso, Adriana O.
    Brindeiro, Rodrigo M.
    Tanuri, Amilcar
    PLOS ONE, 2012, 7 (10):
  • [22] MECHANISMS OF RESISTANCE OF HIV-1 RT TO NUCLEOSIDE AND NONNUCLEOSIDE INHIBITORS
    BOYER, PL
    TANTILLO, C
    DING, JP
    FERRIS, AL
    CLARK, P
    ARNOLD, E
    HUGHES, SH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 150 - MEDI
  • [23] DEVELOPMENT OF RESISTANCE TO THE BHAP NONNUCLEOSIDE HIV-1 RT INHIBITORS
    POPPE, SM
    DUEWEKE, TJ
    PUSHKARSKAYA, T
    STEVENSON, M
    CHEN, ISY
    TARPLEY, WG
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 84 - 84
  • [24] Involvement of novel HIV-1 reverse transcriptase mutations in the highly ordered regulation of NRTI resistance
    Ceccherini-Silberstein, F
    Svicher, V
    Sing, T
    Santoro, M
    Beerenwinkel, N
    Gago, F
    Bertoli, A
    Forbici, F
    Bellocchi, MC
    Narciso, P
    Monforte, AD
    Antinori, A
    Perno, CF
    ANTIVIRAL THERAPY, 2005, 10 : S106 - S106
  • [25] MD simulation of resistent effect of HIV-1 RT mutation to NNRTI
    Zhou, ZG
    Madura, JD
    Madrid, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U763 - U763
  • [26] HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes
    Cilento, Maria E.
    Wen, Xin
    Reeve, Aaron B.
    Ukah, Obiaara B.
    Snyder, Alexa A.
    Carrillo, Ciro M.
    Smith, Cole P.
    Edwards, Kristin
    Wahoski, Claudia C.
    Kitzler, Deborah R.
    Kodama, Eiichi N.
    Mitsuya, Hiroaki
    Parniak, Michael A.
    Tedbury, Philip R.
    Sarafianos, Stefan G.
    VIRUSES-BASEL, 2023, 15 (10):
  • [27] The HIV-1 Reverse Transcriptase M184I Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral Fitness
    Kulkarni, Rima
    Babaoglu, Kerim
    Lansdon, Eric B.
    Rimsky, Laurence
    Van Eygen, Veerle
    Picchio, Gaston
    Svarovskaia, Evguenia
    Miller, Michael D.
    White, Kirsten L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (01) : 47 - 54
  • [28] SPECIFIC HIV-1 INHIBITORS TARGETED AT THE HIV-1 RT
    DECLERCQ, E
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 673 - 673
  • [29] NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatment
    Marcelin, A. G.
    Visseaux, B.
    Wirden, M.
    Morand-Joubert, L.
    Soulie, C.
    Charpentier, C.
    Masquelier, B.
    Descamps, D.
    Calvez, V.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (02) : 103 - 106
  • [30] Replicative fitness of a panel of prototypical HIV-1 containing multiple NRTI-resistance mutations
    Weber, J.
    Mirza, M.
    Jegede, O.
    Weberova, J.
    Shafer, R. W.
    Quiñones-Mateu, M. E.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S48 - S48
12345